Cholestyramine for Bile Acid Malabsorption Diarrhea

Initial Dosing and Titration

The American Gastroenterological Association recommends starting cholestyramine at a low dose of 4 grams once daily, then gradually titrating upward based on clinical response to a typical maintenance dose of 8-16 grams daily divided into two doses, with a maximum of 24 grams daily if needed 1
Begin with 4 grams once daily, taken with meals or as needed to avoid interference with other medications, and increase gradually to minimize side effects, particularly constipation, bloating, and abdominal discomfort 1, 2

Cholestyramine is successful in approximately 70% of patients with bile acid malabsorption overall, with response rates varying by severity 3, 4
The American Gastroenterological Association advises avoiding cholestyramine in patients with Crohn's disease and extensive ileal resection (>100 cm), as it can paradoxically worsen steatorrhea and increase caloric loss 1

Once symptoms are controlled, attempt intermittent on-demand dosing rather than continuous daily therapy to minimize side effects, improve compliance, and reduce costs 5
Consider colesevelam (625 mg tablets, 3 tablets twice daily or 6 tablets once daily) as second-line bile acid sequestrant, with a 47-57% response rate in cholestyramine failures 2

In patients with microscopic colitis and concurrent bile acid malabsorption, cholestyramine may improve diarrhea symptoms but does not affect histopathology 6
Cholestyramine is effective in the majority of patients with postcholecystectomy diarrhea, with 23 of 26 patients responding in one study 1

The American Gastroenterological Association recommends starting cholestyramine at 4 grams once daily and gradually titrating to a maintenance dose of 8-16 grams daily divided into two doses, with response expected in approximately 70% of patients with bile acid malabsorption 7
Cholestyramine achieves clinical response in approximately 70% of patients overall with bile acid malabsorption, with response rates varying by severity: 67% in patients with SeHCAT retention <5%, 73% with retention <8-11.7%, and 59% with retention <15% 7
One RCT showed a significant 92.4% reduction in watery stools per day with cholestyramine versus 75.8% with hydroxypropyl cellulose (p=0.048) 7

Approximately 11% of patients find cholestyramine intolerable due to unpalatability or side effects, with 45% of treatment failures related to medication intolerance 7
Most common side effects include abdominal bloating and pain, constipation, dyspepsia, nausea, flatulence, and rarely worsening diarrhea 7

For cancer patients with bile salt malabsorption, bile acid sequestrants may be an active adjuvant therapy (Level III, Grade B evidence) 8
The Canadian Association of Gastroenterology suggests using cholestyramine over other bile acid sequestrants as initial therapy, though this is a conditional recommendation based on very-low-certainty evidence 7

The British Society of Gastroenterology and the Canadian Association of Gastroenterology recommend starting cholestyramine at 4 grams once daily and increasing gradually every few days, with clinical experience suggesting increases of approximately 4 grams every 2-3 days as tolerated, titrating to symptom control up to a maintenance dose of 8-16 grams daily divided into two doses, to improve tolerance and minimize side effects 9, 10
Taking the medication with food significantly reduces gastrointestinal side effects like bloating, nausea, and abdominal discomfort, according to the Canadian Association of Gastroenterology 10

The Canadian Association of Gastroenterology designates gradual daily dose titration as a "good practice statement" to minimize side effects, with the specific recommendation to slowly titrate to symptoms 9
The British Society of Gastroenterology recommends increasing the dose gradually over "a few days" according to clinical experience, with increases of approximately 4 grams every 2-3 days as tolerated until symptoms improve 10

Once symptoms are controlled, the Canadian Association of Gastroenterology recommends using the lowest dose needed to maintain symptom control, typically 8-16 grams daily divided into two doses 9

The Canadian Association of Gastroenterology recommends avoiding cholestyramine entirely in patients with Crohn's disease and extensive ileal resection (>100 cm), as it paradoxically worsens steatorrhea 9

If side effects are intolerable during titration, the British Society of Gastroenterology recommends considering starting at an even lower dose (¼ sachet = 1 gram) and increasing more slowly 10
The Canadian Association of Gastroenterology recommends switching to colesevelam (625 mg tablets, starting at 3 tablets twice daily) if cholestyramine remains poorly tolerated, as it has fewer side effects 9

Once symptoms are controlled, the Canadian Association of Gastroenterology recommends attempting intermittent on-demand dosing rather than continuous daily therapy to minimize side effects and improve compliance 9
If symptoms recur or worsen despite stable dosing, the Canadian Association of Gastroenterology recommends conducting diagnostic re-evaluation rather than simply increasing the dose 9